| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Aug―12 |
COVID-19 pandemic impact on pediatric hospitalization dynamics for acute intestinal infections (including rotavirus) in Chita |
E. V. Andreeva, N. A. Miromanova, L. I. Bry`lyova |
| 2 |
[GO] |
2026―Aug―12 |
Phenotypic composition of peripheral blood monocytes in young patients with COVID-19 and its association with the risk of acute myocardial infarction |
I. A. Andrievskaya, A. S. Shulga, K. S. Lyazgiyan |
| 3 |
[GO] |
2026―Aug―12 |
Risk prediction of post-COVID conditions using NLRP3 and GSDMD markers in patients with bronchial asthma after COVID-19 |
T. G. Lobova, T. I. Vitkina |
| 4 |
[GO] |
2026―May―28 |
Indicators of the innate immune system in patients with severe COVID-19 and their role in the development of coagulopathy |
T. V. Gaydukova, T. O. Burdienko, E. V. Fefelova, P. P. Tereshkov, S. A. Lukyanov, N. N. Tsybikov |
| 5 |
[GO] |
2026―Jan―23 |
Clinical and hemostatic features in children with varying severity of COVID-19 in Irkutsk |
M. V. Gomellya, T. S. Krupskaya, A. N. Vorzhеva, A. V. Mironova |
| 6 |
[GO] |
2025―Dec―19 |
Serum phospholipid and selected oxylipin levels in second-trimester pregnant women with COVID-19 |
N. A. Ishutina, I. A. Andrievskaya |
| 7 |
[GO] |
2025―Jul―28 |
The relationship between past coronavirus infection and the content of serum interleukins in diseases of the nervous system |
P. E. Borodin |
| 8 |
[GO] |
2025―Jul―28 |
Echocardiographic changes after COVID-19 infection with lung damage and their association with manifestations of post-COVID syndrome (prospective 6-month follow-up) |
E. A. Grigoricheva, G. R. Gessen, T. V. Serova, L. V. Bazarkina |
| 9 |
[GO] |
2025―May―19 |
The dynamic assessment of immune status in children after a new coronavirus infection |
E. V. Moskaleva, A. G. Petrova, L. V. Rychkova, E. A. Novikova, I. V. Kozlova, L. I. Kolesnikova |
| 10 |
[GO] |
2025―May―19 |
Student health care practices: assessing the long-term effects of the COVID-19 pandemic |
S. S. Gordeeva, A. S. Shlyapina, N. A. Lebedeva-Nesevria |
| 11 |
[GO] |
2025―Mar―24 |
Effect of phytocomposition on dyslipidemia in patients with SARS-CoV-2 infection at the health resort stage of treatment |
I. A. Yatskov, L. Sh. Dudchenko, F. M. Melikov, V. A. Beloglazov, E. A. Solovyova, G. N. Andreeva |
| 12 |
[GO] |
2025―Mar―24 |
Assessment of the inflammatory response in convalescents of a new coronavirus infection in the catamnesis |
T. G. Lobova, T. I. Vitkina |
| 13 |
[GO] |
2025―Mar―24 |
Phenotypic composition of umbilical blood monocytes and health status of newborns from mothers with COVID-19 |
I. A. Andrievskaya, K. S. Lyazgiyan, E. M. Ustinov |
| 14 |
[GO] |
2025―Jan―27 |
High seroprevalence to SARS-CoV-2 among healthcare and non-healthcare workers of the ophthalmology center |
N. V. Palyanova, M. G. Chechenin, A. N. Trunov, I. A. Sobolev, A. M. Shestopalov |
| 15 |
[GO] |
2025―Jan―27 |
Pro-inflammatory and anti-inflammatory cytokines in neonates during the acute period of novel coronavirus infection |
E. V. Moskaleva, A. G. Petrova, L. V. Rychkova, L. F. Sholokhov, M. R. Akhmedzyanova, N. V. Semenova, et al. (+3) E. A. Novikova, A. A. Kharkhorina, L. I. Kolesnikova |
| 16 |
[GO] |
2025―Jan―27 |
Predicting the risk of developing drug-induced liver injury during remdesivir therapy in COVID-19 patients using machine learning |
Yu. V. Shevchuk, I. I. Shamigulov, I. V. Sychev, A. V. Kryukov, I. I. Temirbulatov, K. B. Mirzaev, et al. (+6) N. P. Denisenko, Sh. P. Abdullaev, S. N. Tuchkova, V. I. Vechorko, O. V. Averkov, D. A. Sychev |
| 17 |
[GO] |
2024―Nov―25 |
Immune status in women after COVID-19 living in the subarctic region |
L. S. Shchegoleva, E. Yu. Shashkova, M. S. Kabbani, O. E. Filippova |
| 18 |
[GO] |
2024―Nov―25 |
Clinical and neurological manifestations of COVID-19 and other coronavirus infections: A literature review |
V. A. Beloborodov, I. A. Stepanov, E. A. Kelchevskaya, V. A. Vorobiev, A. P. Frolov, M. A. Kozhevnikov, et al. (+3) A. R. Tukhiev, V. E. Borisov, Z. S. Saakyan |
| 19 |
[GO] |
2024―Nov―25 |
Metabolic processes of prostaglandin metabolism in women at 28-30 weeks of gestation with COVID-19 |
N. A. Ishutina, I. A. Andrievskaya |
| 20 |
[GO] |
2024―Nov―25 |
Using essential oils in rehabilitation of olfactory disorders in patients who have had a new coronavirus infection |
V. A. Beloglazov, E. V. Burtseva, I. A. Yatskov, K. V. Bubley, A. S. Novosad, N. A. Shadchneva |
| 21 |
[GO] |
2024―Sep―30 |
Pathogenesis of respiratory failure in COVID-19 due to coagulopathy and endothelial dysfunction |
T. O. Burdienko |
| 22 |
[GO] |
2024―Sep―30 |
Low-grade systemic inflammation in patients with long COVID: The role of imbalance of endotoxin-releasing systems and vasoconstrictor markers |
V. A. Beloglazov, L. Sh. Dudchenko, R. Kh. Useinova, I. A. Yatskov, E. A. Solovyova, G. N. Andreeva |
| 23 |
[GO] |
2024―Jul―24 |
Levels of markers of coagulation and fibrinolysis systems in patients with pulmonary tuberculosis with concomitant diabetes mellitus after COVID-19 |
R. Yu. Abdullaev, O. G. Komissarova, V. A. Shorokhova |
| 24 |
[GO] |
2024―Jun―03 |
Menopausal women with moderate and asymptomatic COVID-19: antioxidant defense system biomarkers |
N. V. Semenova, E. V. Vyrupaeva, S. I. Kolesnikov, M. A. Darenskaya, E. A. Novikova, A. G. Petrova, et al. (+2) E. A. Orlova, L. I. Kolesnikova |
| 25 |
[GO] |
2024―Jun―03 |
Assessment of the therapeutic effect of the drug Molixan in the treatment of Syrian hamsters experimentally infected with the SARS-CoV-2 virus |
M. A. Gulyaeva, L. V. Shestopalova, X. Din, A. Yu. Alekseev, A. G. Markhaev, А. Yu. Filippova, et al. (+3) V. G. Antonov, A. P. Trashkov, A. M. Shestopalov |
| 26 |
[GO] |
2024―Jan―19 |
Assessment of consequences of COVID-19 in adolescents by the method of questionnaire |
I. A. Cherevikova, E. A. Tkachuk, V. M. Polyakov, N. S. Vasileva, Zh. V. Prokhorova, A. S. Votineva, N. A. Myasishchev |
| 27 |
[GO] |
2024―Jan―19 |
Attitude and awareness of Indian parents from Kerala state towards children’s vaccination at the COVID-19 pandemic background |
Sureshkumar Ajitha Aaromal, E. A. Novikova, Suprasannan Abhiramy, Krishna Maniyan Girija Manu, A. S. Vanyarkinа, E. V. Moskaleva, et al. (+3) E. D. Kazantseva, A. G. Petrova, L. V. Rychkova |
| 28 |
[GO] |
2024―Jan―19 |
The rs11385942 and rs657152 variants are not associated with COVID-19 severity and outcomes in patients treated with favipiravir and remdesivir |
Sh. P. Abdullaev, N. P. Denisenko, I. I. Temirbulatov, A. A. Kachanova, S. N. Tuchkova, E. V. Mikhaylenko, et al. (+4) A. V. Kryukov, T. T. Valiev, K. B. Mirzaev, D. A. Sychev |
| 29 |
[GO] |
2024―Jan―19 |
Role of <i>ITGB3</i>, <i>GP1B1</i>, and <i>ITGA2</i> gene polymorphisms in platelet dysfunction in patients with COVID-19-associated lung damage |
M. V. Osikov, V. N. Antonov, S. O. Zotov |
| 30 |
[GO] |
2024―Jan―19 |
Coronaviruses in rodents and insectivores in Altai Republic |
L. N. Yashina, S. A. Abramov, N. A. Smetannikova, B. S. Malyshev, A. V. Krivopalov, T. A. Dupal |
| 31 |
[GO] |
2023―Oct―06 |
Features of peripheral blood cellular immunity parameters in patients with lung damage up to 30 % in COVID-19 |
E. A. Borodulina, Zh. P. Vasneva, E. S. Vdoushkina, B. E. Borodulin, L. V. Povalyaeva |
| 32 |
[GO] |
2023―Oct―06 |
Left ventricular diastolic dysfunction and transmitral blood flow parameters in patients after COVID-19 |
V. A. Vasilev, T. T. Karapetyan, V. A. Larionova, I. N. Solyanikova, K. B. Tsekhanovich |
| 33 |
[GO] |
2023―Jul―18 |
Influence of health resort treatment on the level of systemic inflammation in patients after new coronavirus infection |
V. A. Beloglazov, L. Sh. Dudchenko, I. A. Yatskov, E. A. Solovyova, N. A. Shadchneva, S. N. Belyaeva, D. I. Ulyanova |
| 34 |
[GO] |
2023―May―10 |
А clinical case of thrombosis in a teenager in the post COVID-19 period |
L. V. Zhdanova, M. L. Laperdina |
| 35 |
[GO] |
2023―May―10 |
Thyroid status and TNF-alpha in post-reproductive women with COVID-19 and 12 months after the disease |
N. V. Semenova, S. I. Kolesnikov, E. V. Vyrupaeva, L. F. Sholokhov, L. V. Rychkova, А. G. Petrova, et al. (+3) M. R. Akhmedzyanova, M. A. Darenskaya, L. I. Kolesnikova |
| 36 |
[GO] |
2023―May―10 |
The role of circulating miR-19b miRNA in predicting the outcome of COVID-19 |
M. Yu. Shkurnikov, S. I. Kolesnikov |
| 37 |
[GO] |
2023―Mar―13 |
Assessment of indicators of specific humoral immune against COVID-19 in children during the distribution of a new coronavirus infection in the Irkutsk region (2020-2021) |
D. D. Bryukhova, V. I. Dubrovina, N. O. Kiseleva, A. B. Pyatidesyatnikova, K. M. Korytov, S. V. Balakhonov |
| 38 |
[GO] |
2023―Mar―13 |
Cell-mediated and humoral immunity during COVID-19 in the Republic of Crimea |
E. Yu. Zyablitskaya, D. A. Kudlay, S. V. Kolesnik, T. P. Makalish, P. E. Maksimova, Yu. E. Kunitskaya, et al. (+4) O. Yu. Gritskevich, I. O. Golovkin, I. I. Fomochkina, A. V. Kubyshkin |
| 39 |
[GO] |
2023―Mar―13 |
Assessment of the psycho-emotional state of patients after COVID-19-associated pneumonia in relationship with laboratory indicators |
T. I. Petelina, O. A. Guskova, N. A. Musikhina, A. E. Shcherbinina, V. D. Garanina, L. I. Gapon, E. I. Yaroslavskaya |
| 40 |
[GO] |
2023―Jan―11 |
The role of arginine and endothelial nitric oxide synthase in the pathogenesis of Covid-19 complicated by metabolic syndrome |
L. A. Kuznetsova, N. E. Basova |
| 41 |
[GO] |
2023―Jan―11 |
Cognitive and emotional impairments associated with COVID-19 (literature review) |
V. M. Polyakov, I. A. Cherevikova, N. A. Myasishchev, L. V. Rychkova, A. S. Kosovtseva, A. S. Votineva, et al. (+2) Zh. V. Prokhorova, S. I. Kolesnikov |
| 42 |
[GO] |
2022―Dec―14 |
Verification of a case of mixed infection with Lyme disease, tick-borne encephalitis and COVID-19 |
G. N. Leonova, A. L. Shutikova, A. F. Popov, M. Yu. Shchelkanov |
| 43 |
[GO] |
2022―Dec―14 |
Assessment of the general condition and quality of life of women of post-reproductive age after asymptomatic COVID-19 and 12 months after moderate COVID-19 |
E. V. Vyrupaeva, N. V. Semenova, L. V. Rychkova, A. G. Petrova, M. A. Darenskaya, S. I. Kolesnikov, et al. (+2) A. Yu. Sambyalova, L. I. Kolesnikova |
| 44 |
[GO] |
2022―Dec―14 |
Staged treatment of abdominal sepsis in a puerpera with COVID-19 and pancreatonecrosis after cesarean section: case report |
E. G. Grigoryev, L. V. Sereda, N. I. Ayushinova |
| 45 |
[GO] |
2022―Dec―14 |
Efficacy of olocizumab in treatment of COVID-19 patients |
T. V. Goma, A. N. Kalyagin, O. V. Ryzhkova, N. S. Soloveva |
| 46 |
[GO] |
2022―Dec―14 |
ELISPOT assay of the SARS-CoV-2 specific T cells immune response |
V. V. Gerasimova, S. V. Kolesnik, D. A. Kudlay, A. S. Golderova |
| 47 |
[GO] |
2022―Jul―11 |
Health-saving practices of young people under pandemic conditions: A pilot study |
N. L. Antonova, A. P. Maltseva |
| 48 |
[GO] |
2022―May―26 |
Efficacy and safety of ultra-low dose inhaled melphalan in the treatment of hospitalized patients with COVID-19 |
E. A. Sinitsyn, A. A. Zykova, R. V. Shamin, A. V. Rvacheva, A. O. Bogatyreva, T. V. Shapovalenko, et al. (+2) G. G. Maryin, K. A. Zykov |
| 49 |
[GO] |
2022―Mar―22 |
Influence of antibiotic therapy on indicators of endotoxinemia and systemic inflammation in acute SARS-CoV-2 lung damage |
I. A. Yatskov, V. A. Beloglazov, A. V. Kubyshkin, A. P. Nikolaeva, N. A. Shadchneva, E. Yu. Zyablitskaya, et al. (+2) Yu. E. Kunitskaya, N. E. Lavrenchuk |
| 50 |
[GO] |
2021―Dec―28 |
A clinical case of central retinal artery occlusion after pneumonia caused by SARS-CoV-2 (COVID-19) |
K. L. Latigan, D. A. Latigan, K. E. Dubnov, E. V. Bykova, D. A. Nefedov |
| 51 |
[GO] |
2021―Dec―28 |
Antioxidant status in children and adolescents with COVID-19 |
L. V. Rychkova, M. A. Darenskaya, N. V. Semenova, S. I. Kolesnikov, A. G. Petrova, O. A. Nikitina, et al. (+3) A. S. Brichagina, E. A. Kudeyarova, L. I. Kolesnikova |
| 52 |
[GO] |
2021―Dec―28 |
Clinical and epidemiological characteristics and effectiveness of antiviral therapy for COVID-19 in children: The experience of the first year of the pandemic |
T. M. Chernova, E. B. Pavlova, V. N. Timchenko, E. O. Ermakova, S. Yu. Uskova, A. A. Astakhova, et al. (+2) I. A. Egorova, A. A. Zherebtsova |
| 53 |
[GO] |
2021―Dec―28 |
The possibilities of quantitative analysis of the relationship between the severity of the COVID-19 pandemic and the institutional characteristics of the countries of the world |
A. L. Demchuk, V. M. Kapistyn, A. Yu. Karateev, N. N. Emelyanova, I. V. Dashkina, M. M. Pashin, S. I. Kolesnikov |
| 54 |
[GO] |
2021―Dec―28 |
Blood circulation changes associated with switching to non-invasive ventilation in COVID-19 patients |
D. S. Shilin, Yu. K. Shapovalov, K. G. Shapovalov |
| 55 |
[GO] |
2021―Nov―23 |
Herd immunity to SARS-COV-2 in the population of the Southern regions of the Far East of Russia |
A. Yu. Popova, V. S. Smirnov, E. B. Ezhlova, A. A. Melnikova, O. E. Trotsenko, O. P. Kurganova, et al. (+11) T. N. Detkovskaya, L. V. Lyalina, E. I. Abbasova, O. M. Yurgina, O. B. Romanova, E. V. Pyatyrova, E. N. Burdinskaya, A. S. Solokhin, E. V. Bogdan, E. A. Bazykina, A. A. Totolian |
| 56 |
[GO] |
2021―Oct―18 |
Overview of potential drugs for the treatment of new coronavirus Infection (COVID-19) |
Ya. E. Shirobokov, E. P. Gladunova, E. A. Borodulina, A. E. Sukhanova |
| 57 |
[GO] |
2021―Oct―18 |
Coronavirus disease 2019 (COVID-19): NETosis-associated mechanisms of progression and prospects for therapy regulating the formation of neutrophil extracellular traps (NETs) |
K. A. Aitbaev, I. T. Murkamilov, V. V. Fomin, I. O. Kudaibergenova, F. A. Yusupov |
| 58 |
[GO] |
2021―Oct―18 |
Population immunity to SARS-CoV-2 virus in residents of the Irkutsk Region in the dynamics of the epidemic |
S. V. Balakhonov, V. I. Dubrovina, M. V. Chesnokova, D. D. Bryukhova, N. O. Kiseleva, A. B. Pyatidesyatnikova, et al. (+5) K. M. Korytov, V. V. Voitkova, A. N. Perezhogin, T. A. Gavrilova, A. A. Seledtsov |
| 59 |
[GO] |
2021―Aug―17 |
Structure of herd immunity to SARS-COV-2 in the Krasnoyarsk region population in the COVID-19 epidemic |
A. Yu. Popova, E. B. Ezhlova, A. A. Melnikova, V. S. Smirnov, L. V. Lyalina, D. V. Goryaev, et al. (+10) D. A. Khodov, T. G. Chepizhko, M. V. Rusin, N. N. Kuznetsova, E. Yu. Bezruchko, A. S. Kochergina, V. R. Karimov, A. A. Sharova, V. V. Vetrov, A. A. Totolian |
| 60 |
[GO] |
2021―Aug―17 |
COVID-19-associated coagulopathy in children and adolescents |
M. V. Gomellya, A. V. Tatarinova, T. S. Krupskaya, L. V. Rychkova |
| 61 |
[GO] |
2021―Jun―24 |
Indicators of the Immune Status in Children after a New Coronavirus Infection |
E. V. Moskaleva, A. G. Petrova, L. V. Rychkova, E. A. Novikova, A. S. Vanyarkinа |
| 62 |
[GO] |
2021―Jun―24 |
Retrospective of International Serological Studies on the Formation and Dynamics of the Humoral Immune Response to SARS-CoV-2: from 2020 to 2021 |
E. A. Novikova, A. G. Petrova, E. V. Moskaleva, A. S. Vanyarkinа, L. V. Rychkova |
| 63 |
[GO] |
2021―Apr―11 |
Features of Hematological and Hemostasiological Parameters in Coronavirus Infection COVID-19 and Community-Acquired Pneumonia |
E. A. Borodulina, Zh. P. Vasneva, E. S. Vdoushkina, B. E. Borodulin, L. E. Povalyaeva |
| 64 |
[GO] |
2021―Apr―11 |
Viral Load in COVID-19: Underestimated Clinical and Epidemiological Marker |
E. A. Orlova, O. B. Ogarkov, S. N. Zhdanova, P. A. Khromova, V. V. Sinkov, M. A. Khasnatinov, et al. (+2) L. A. Rychkova, L. I. Kolesnikova |
| 65 |
[GO] |
2020―Nov―09 |
Studying Humoral Immune Response at Mild and Asymptomatic COVID-19 Forms |
S. V. Balakhonov, V. I. Dubrovina, M. V. Chesnokova, V. V. Voitkova, A. B. Pyatidesyatnikova, D. D. Bryukhova, et al. (+4) N. O. Kiseleva, K. M. Korytov, T. G. Kuznetsova, Zh. V. Markevich |
